COMP <GO>
AHG vs NUTX // GROSS PROFIT MARGIN
Akso Health Group ADS (NASDAQ) VS. Nutex Health Inc. (NASDAQ) • 15-METRIC TALLY: AHG 1
— NUTX 7
▲ GROSS PROFIT MARGIN LEADER: NUTX
LAST: $1.33 (+2.31%) • MKT CAP: $1.14B
gross-margins
-0.10%
LAST: $210.10 (-1.19%) • MKT CAP: $1.44B
gross-margins
50.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHG VS. NUTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHG | NUTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | -0.10% | 50.80% | -50.90 | NUTX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 85.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 4.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.12% | 17.07% | -18.19 | NUTX | /fcf-yield <GO> |
| Operating Margin | -60.00% | 31.50% | -91.50 | NUTX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 8.10% | -68.10 | NUTX | /net-margins <GO> |
| Revenue Growth (YoY) | -6.40% | 82.40% | -88.80 | NUTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.75 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 9/9 | -7.00 | NUTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.6 | 53.8 | +3.80 | AHG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.14B | $1.44B | -$299.3M | NUTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHG REV | NUTX REV | AHG GROSS % | NUTX GROSS % | AHG FCF | NUTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.8M | $875.3M | -0.1% | 50.8% | -$12.8M | $245.6M |
| FY 2024 | $14.8M | $479.9M | -1.9% | 40.9% | $1.0M | $20.8M |
| FY 2023 | $2.4M | $247.6M | — | — | $1.4M | $1.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHG // BETA —
NUTX // BETA —